fashion -WSS

fashion

author：fashion 2025-09-28 01:37:09 - browse：289

The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year. Adobe

The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year, a cut that’s more than eight times larger than the one proposed in April.

The Centers for Medicare and Medicaid Services originally said it would cut payments meant to help safety net hospitals by $115 million in 2024. In the final rule released this week, however, that cut grew to $957 million. The pool of money is known as Medicare’s disproportionate share hospital (DSH) payments and uncompensated care payments.

The agency finalized a bigger cut because it lowered its estimated uninsured rate for next year. CMS explained that even though Medicaid enrollment will shrink as states redetermine members’ eligibility, many of those who didn’t lose Medicaid coverage during the pandemic have since gotten or will get insurance from other sources, like employers — and therefore they will remain insured even when they’re kicked off Medicaid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： How a Boston hospital is priming medical residents to use GPT

leisure time

WSS

Gilead might be held responsible for not developing a drug

Sanders wants to replace patents with prizes for drug inventions

For Medicare Advantage, Democrats want stronger protections around AI

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

When a patient nears the end, a feared therapy can comfort

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

hotspot

fashion

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

The dental labor crisis is a moment of opportunity

23andMe had bad news about my health. I wish a person had delivered it

Gilead might be held responsible for not developing a drug

BioMarin wins approval for gene therapy to treat hemophilia A

The stock market has soared this year, but will it last? Experts weigh in

Psychedelics group wrestles with new pharma identity

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Peter Hotez and the public health issue of online harassment

Sanders wants to replace patents with prizes for drug inventions

Wikipedia

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

The Readout: Gilead, Bernie Sanders, and other pharma news

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Medicare Advantage proposed rates disappoint insurers

Why did Pfizer dish out millions for a Super Bowl ad?

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

leisure time

Wikipedia

leisure time

focus